Get ready for the premier Quality Assurance event of 2025 - see full program and registration form below!
SARQA/DKG are thrilled to announce The 11th Scandinavian SARQA/DKG Quality Assurance Conference taking place on October 22nd, 2025, at DGI Byen Conference in Copenhagen.

This year, we're diving into Artificial Intelligence – how it can be used within our industry – and not least the critical challenges in relation to quality assurance.

Join fellow QA professionals from across the life science sector to gain invaluable insights from industry subject matter experts and supporting service providers.

This is your opportunity to:
·   Understand the transformative potential of AI in pharma
·   Explore practical applications and real-world case studies
·   Discuss and address the unique QA challenges presented by AI
·   Network with peers and leaders

The registration deadline is October 8th, 2025, and it will be on first-come, first-served basis, as there is a limited number of seats. Registration form: https://forms.gle/yAz7qZGWMY1epf5y7

Conference content:

• The Intelligent Compliance Revolution: How AI Elevates Human Expertise in Life Science QA 
  Fabrizio Maniglio, Honeywell / Chair for the RQA IT Committee
• AI Adoption - Change, Leadership and Strategy
  Marcelina Dutkeiwitz, Efficiency Tactics
• Embedding and Leveraging AI for Quality in Pharma by IMPALA*
  Martin Simàn, AstraZeneca and Haleh Valian, Biogen, both representing IMPALA*
• Security, AI act, Requirements and Validation (preliminary title)
  Mads Bo Christensen, DAQUMA
• Popcorn, People & Prompts: How One QA Department Made AI Pop
  Lene Holm Jakobsen, Genmab
• AI or AIEEE!! Evaluating the Help and Hindrance of Technology in GXP Systems
  Louise Mawer, Mirabilitas Ltd (former MHRA Inspector)
• AI in GXP: What Works, What Fails, and How to Tell the Difference?
  Hans de Raad, OpenNovations and Nick Larsen, PharmaIT / Representatives for the RQA IT Committee
• AI at the Agencies and New Regulations
  Joint presentations from the Danish Medicines Agency (DKMA) and the Swedish Medicinal Products Agency (MPA)
• Annex 22, Artificial Intelligence
  Ib Alstrup, Medicines Inspector, GXP IT at DKMA
• AI at the Agency
  Samuel Fransson, Data Scientist, AI Unit at MPA

Click here for full program in pdf:

Find your way to DGI Byen Conference - https://www.dgibyen.dk/da/find-vej/find-vej-til-cph-conference

Nearby hotels:

• Scandic Kødbyen - https://www.scandichotels.com/da/hoteller/scandic-kodbyen
• Axel Guldsmeden - https://guldsmedenhotels.com/axel-guldsmeden-spa-hotel/?utm_source=GBP&utm_medium=organic&utm_campaign=Axel+Guldsmeden+Eco-friendly+Spa+Hotel&utm_content=website_button_GBP
• Other - https://www.trivago.com/

*IMPALA - The Inter coMPany quALity Analytics (IMPALA) Consortium was initially established in July 2019 as an informal group of biopharmaceutical organizations with the common goal to share knowledge and better understand opportunities in applying advanced analytics for QA - see https://impala-consortium.org/